Sanofi’s brivekimig met the primary endpoint in a Phase IIa trial in patients naïve to biologics with moderate-to-severe ...

Covered call ETFs like GPIQ and GPIX offer retirees attractive income streams, especially when held in tax-advantaged ...

AppLovin is posting 77% yoy revenue growth, 81% margins, and gearing up for e-commerce and international ad catalysts. Read ...